OBI Pharma, Inc. (4174.TWO)
TWD 58.3
(-2.18%)
TWD 58.3
(-2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.65 Billion | -1.61 Billion | -1.06 Billion | -1.6 Billion | -1.04 Billion | -864.3 Million |
| Net Income | -1.27 Billion | -1.91 Billion | -1.74 Billion | -1.49 Billion | -1.44 Billion | -1.25 Billion |
| Depreciation & Amortization | 248.95 Million | 246.61 Million | 216.27 Million | 231.83 Million | 167.41 Million | 122.61 Million |
| Deferred income taxes | -599.02 Million | - | 33.42 Million | 2.73 Million | 88.18 Million | 110.42 Million |
| Stock-based compensation | 119.19 Million | 148.99 Million | 54.01 Million | 76.82 Million | 146.12 Million | 231.29 Million |
| Change in working capital | -63.53 Million | -92.37 Million | 376.71 Million | -388.14 Million | 84.71 Million | 14.51 Million |
| Other non-cash items | -83.01 Million | -5.84 Million | -2.66 Million | -39 Million | -88.11 Million | -87.34 Million |
| Investing Cash Flow | -2.79 Billion | -169.88 Million | 82.67 Million | -195.9 Million | -53.07 Million | 1.98 Billion |
| Investments in PPE | -108.16 Million | -300.55 Million | -245.18 Million | -185.64 Million | -51.57 Million | -20.76 Million |
| Acquisitions | -360.63 Million | 54 Thousand | 472.65 Million | 18.36 Million | - | 10.7 Million |
| Investment purchases | -3.29 Billion | -30.71 Million | -140 Million | - | - | 621 Thousand |
| Sales/Maturities of investments | 983.03 Million | 140 Million | -3.85 Million | - | - | 2.02 Billion |
| Other Investing Activities | -12.96 Million | 21.32 Million | -932 Thousand | -28.61 Million | -1.5 Million | -32.83 Million |
| Financing Cash Flow | 607.06 Million | 4 Billion | 163.74 Million | 283.09 Million | 1.98 Billion | -7.5 Million |
| Debt repayment | -51.61 Million | -7 Million | -18.46 Million | -9 Million | -9 Million | -9 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -93.45 Million | - |
| Common Stock Issuance | 652.47 Million | 3.15 Billion | 17.51 Million | 22.93 Million | 2.02 Billion | 1.5 Million |
| Other Financing Activities | 658.68 Million | 866.98 Million | 164.69 Million | 269.15 Million | 159.2 Million | 1.5 Million |
| Accounts receivables | -16.11 Million | 11.4 Million | -5.15 Million | -929 Thousand | -1.92 Million | -3.04 Million |
| Accounts payables | -371 Thousand | 619 Thousand | 368 Thousand | -20 Thousand | 114 Thousand | - |
| Inventory | -3.95 Million | -9.74 Million | -2.2 Million | -3.15 Million | 907 Thousand | - |
| Other working capital | -43.09 Million | -94.65 Million | 383.7 Million | -384.03 Million | 85.62 Million | 17.55 Million |
| Cash at beginning of period | 4.74 Billion | 2.51 Billion | 3.33 Billion | 4.86 Billion | 3.66 Billion | 2.55 Billion |
| Cash at end of period | 899.27 Million | 4.74 Billion | 2.51 Billion | 3.33 Billion | 4.55 Billion | 3.66 Billion |
| Capital Expenditure | -108.16 Million | -300.55 Million | -245.18 Million | -185.64 Million | -51.57 Million | -20.76 Million |
| Effect of forex changes on cash | -559 Thousand | 8.52 Million | -8.06 Million | 539 Thousand | -1.84 Million | 739 Thousand |
| Net cash flow / Change in cash | -3.84 Billion | 2.22 Billion | -826.11 Million | -1.52 Billion | 886.52 Million | 1.1 Billion |
| Free Cash Flow | -1.76 Billion | -1.92 Billion | -1.3 Billion | -1.79 Billion | -1.09 Billion | -885.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -540.66 Million | -522.25 Million | -1.27 Billion | -563.12 Million | -626.89 Million | 337 Million |
| Depreciation & Amortization | 54.02 Million | 53.29 Million | 248.95 Million | 56.3 Million | 67.39 Million | 58.94 Million |
| Deferred income taxes | - | - | -599.02 Million | 76.47 Million | 102.69 Million | -803.04 Million |
| Stock-based compensation | 7.27 Million | 17.19 Million | 119.19 Million | 15.69 Million | 36.96 Million | 35.32 Million |
| Change in working capital | -13.94 Million | -45 Million | -63.53 Million | 4.96 Million | -10.49 Million | -3.38 Million |
| Other non-cash items | 135.07 Million | 104.8 Million | -83.01 Million | -16.87 Million | -16.13 Million | -26.19 Million |
| Investing Cash Flow | 310.01 Million | 885.02 Million | -2.79 Billion | -719.67 Million | -208.84 Million | -1.52 Billion |
| Investments in PPE | -33.82 Million | -53.34 Million | -108.16 Million | -29.61 Million | -22.81 Million | -40.44 Million |
| Acquisitions | -30.41 Million | 144.63 Million | -360.63 Million | -1.52 Million | 203.44 Million | -564.08 Million |
| Investment purchases | -653.8 Million | - | -3.29 Billion | -1.64 Billion | -389.41 Million | -901.08 Million |
| Sales/Maturities of investments | 1.02 Billion | 789.92 Million | 983.03 Million | 952.32 Million | -1.35 Million | 564.08 Million |
| Other Investing Activities | 1.85 Million | 3.8 Million | -12.96 Million | 4.37 Million | 1.29 Million | -579.61 Million |
| Financing Cash Flow | 2.88 Million | 7.83 Million | 607.06 Million | -7.89 Million | -13.32 Million | -11.84 Million |
| Debt repayment | -16.45 Million | -12.97 Million | -51.61 Million | -7.89 Million | -18.99 Million | -11.72 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 652.47 Million | -17.6 Million | 3.3 Million | 14.3 Million |
| Other Financing Activities | -629 Thousand | -3000.00 | 658.68 Million | 17.6 Million | 5.67 Million | -123 Thousand |
| Accounts receivables | 2.45 Million | 305 Thousand | -16.11 Million | -5.42 Million | -3.97 Million | -7.64 Million |
| Accounts payables | 2.79 Million | 58 Thousand | -371 Thousand | -2.73 Million | -1.21 Million | 4.56 Million |
| Inventory | -9.51 Million | 1.5 Million | -3.95 Million | -213 Thousand | 479 Thousand | -2.51 Million |
| Other working capital | -9.67 Million | -46.87 Million | -43.09 Million | 13.34 Million | -5.78 Million | 2.21 Million |
| Cash at beginning of period | 1.28 Billion | 899.27 Million | 4.74 Billion | 2.05 Billion | 2.72 Billion | 4.65 Billion |
| Cash at end of period | 1.12 Billion | 1.28 Billion | 899.27 Million | 899.27 Million | 2.05 Billion | 2.72 Billion |
| Capital Expenditure | -33.82 Million | -53.34 Million | -108.16 Million | -29.61 Million | -22.81 Million | -40.44 Million |
| Effect of forex changes on cash | 3.49 Million | 3.81 Million | -559 Thousand | -5.56 Million | 4.16 Million | 2.65 Million |
| Net cash flow / Change in cash | -161.43 Million | 382.78 Million | -3.84 Billion | -1.15 Billion | -664.47 Million | -1.93 Billion |
| Free Cash Flow | -511.65 Million | -567.22 Million | -1.76 Billion | -456.17 Million | -469.28 Million | -441.79 Million |
F3A
2305
BURCF
RICA
DHG
3057